Study on the Intervention Effect of Qi Gong Wan Prescription on Patients with Phlegm-Dampness Syndrome of Polycystic Ovary Syndrome Based on Intestinal Flora
Table 2
Comparison of clinical baseline data before and after treatment in PCOS patients with phlegm-dampness.
Characteristic
PCOS with phlegm-dampness group before treatment (n = 20)
PCOS with phlegm-dampness group after treatment (n = 20)
value
value
BMI (kg/m2)
32.23 ± 5.06
29.56 ± 3.93
−3.921
< 0.001
Waist circumference (cm)
88.8 ± 6.16
82.05 ± 5.09
−3.924
< 0.001
Hip circumference (cm)
99.9 ± 2.65
98.3 ± 2.13
−3.335
0.001
WHR
0.89 ± 0.04
0.83 ± 0.04
−3.893
< 0.001
FPG (mmol/L)
5.8 ± 0.5
5.37 ± 0.35
−3.105
0.002
FINS (μU/mL)
22.66 ± 10.66
13.27 ± 5.89
−3.743
< 0.001
HOMA-IR
5.94 ± 3.02
3.18 ± 1.47
−3.783
< 0.001
FSH (mIU/mL)
6.59 ± 1.27
6.78 ± 0.97
−0.504
0.614
LH (mIU/mL)
10.77 ± 3.15
6.83 ± 2.06
−3.883
< 0.001
LH: FSH ratio
1.66 ± 0.49
1.02 ± 0.31
−3.921
< 0.001
Prolactin (ng/mL)
11.45 ± 6.62
10.62 ± 4.95
−0.803
0.422
Testosterone (ng/mL)
0.74 ± 0.24
0.65 ± 0.15
−1.195
0.232
Data are presented as mean ± SD. Abbreviation: PCOS, polycystic ovary syndrome; BMI, body mass index; WHR: waist-to-hip ratio; FPG, fasting plasma glucose; FINS, fasting plasma insulin; HOMA-IR, homeostasis model assessment of insulin resistance; FSH, follicular stimulating hormone; LH, luteinizing hormone. There is a significant difference between the two groups (<0.05); difference is highly significant (<0.01).